TaiGen Biotechnology Company, Limited today announced that the U.S. Food and Drug Administration has granted nemonoxacin Qualified Infectious Disease Product and Fast Track designations for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections .
http://www.drugs.com/clinical_trials/nemonoxacin-gets-fda-fast-track-designation-16405.html?
http://www.drugs.com/clinical_trials/nemonoxacin-gets-fda-fast-track-designation-16405.html?
No comments:
Post a Comment